2016
DOI: 10.1099/jgv.0.000610
|View full text |Cite
|
Sign up to set email alerts
|

Biosafety standards for working with Crimean-Congo hemorrhagic fever virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 43 publications
(31 citation statements)
references
References 60 publications
0
31
0
Order By: Relevance
“…The only known human infection with CCHFV in Egypt happened in 1981. An Egyptian virologist died after mouth-pipetting a culture of a CCHFV isolate that he had brought from Iraq [ 324 ].…”
Section: Viral Zoonosismentioning
confidence: 99%
“…The only known human infection with CCHFV in Egypt happened in 1981. An Egyptian virologist died after mouth-pipetting a culture of a CCHFV isolate that he had brought from Iraq [ 324 ].…”
Section: Viral Zoonosismentioning
confidence: 99%
“…Over the last few years, public health interest in CCHFV as an important zoonosis has increased, partly due to its vast geographical range, including its emergence in new foci; its high degree of genetic diversity with the capability for new and potentially highly-pathogenic variants to emerge ( Elevli et al, 2010 ; Salehi-Vaziri et al, 2016 ); and recent discussion on its use as a potential bio-weapon ( Christian, 2013 ). Consequently, CCHFV is classified as a bio-safety level 4 pathogen in countries where the disease is not endemic ( Weidmann et al, 2016 ). Globally, all newly identified cases of CCHF in humans and animals are an internationally notifiable disease, and must be reported to WHO and OIE.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, most reagents used for development of diagnostic tools are dependent on culturing the virus within the confines of a biosafety level 4 facility. The biosafety considerations limit the number of laboratories which are able to prepare reagents [ 10 ]. The current perceived risk of spread of the virus to non-endemic regions highlights the importance of increasing diagnostic capacity and serological surveillance using safe, standardized reagents [ 9 ].…”
Section: Introductionmentioning
confidence: 99%